Updated

New research found that tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, suggesting the drug's metabolic benefits may extend beyond appetite suppression. If confirmed in humans, the discovery could help explain the drug's outsized effects on weight and metabolism and inspire new treatments for obesity and diabetes.